Loading…
Monday, June 15 • 3:30pm - 4:30pm
#134 L: Should a COVID-19 Vaccination be Legally Mandated and Can HTA Inform That Decision?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-569-L04-P; CME 1.00; IACET 1.00; RN 1.00

Health Technology Assessment (HTA) is defined as a multidisciplinary process to evaluate the social, economic, organizational and ethical issues of an intervention or health technology. In anticipation of COVID-19 vaccine, a panel composed of the relevant stakeholders will have an open dialogue about the role of HTA in informing public health policy-making, with particular focus on vaccination, and enforcing such policies at an individual country and global levels. Potential learnings from previous pandemics, such as H1N1, will be reviewed. Ethical and economic challenges will be debated to offer a consensus position that takes into account societal benefits, economic, logistical and legal considerations.

Learning Objectives

Debate the ethical, logistical, and legal implications if a mandated vaccine program were to be instituted and what would inform such a decision; Discuss the role and opportunity of HTA to inform and recommend a decision.

Chair

Richard Hiraiwa Stanford, PharmD, MS

Speaker

Panelist
Richard Hiraiwa Stanford, PharmD, MS

Panelist
Phil Ball, PhD

Panelist
Andrew H. Briggs, PhD, MSc



Speakers
avatar for Phil Ball

Phil Ball

Health Policy, Biopharmaceutical Development Strategy, Independent Consultant
Phil Ball has over twenty years of international experience spanning from pharmaceutical product development to health policy. Most recently he was Executive Director, U.S. Value Policy and Strategy, at Allergan. In this role he led U.S. HEOR- and value-related policy and legislative... Read More →
avatar for Andrew Briggs

Andrew Briggs

Professor of Health Economics, London School of Hygiene and Tropical Medicine (LSHTM)
avatar for Richard Stanford

Richard Stanford

Vice President, Strategic Consulting, AESARA, United States
Dr. Stanford is VP of Strategic Consulting Solutions at AESARA, a digital-forward market access agency that designs innovative solutions that enable transformative market access. In addition, he is an Adjunct Assistant Professor at UNC Eshelman School of Pharmacy. Prior to joining... Read More →


Monday June 15, 2020 3:30pm - 4:30pm EDT
TBD Virtual Event Horsham, PA 19044
  12: Value-Access, Forum
  • LEVEL Intermediate
  • FEATURED TOPICS HTA
  • Featured Topics HTA
  • Credit Type ACPE, CME, IACET, RN
  • Tags Forum